Literature DB >> 11701489

Transport of molecules, particles, and cells in solid tumors.

R K Jain1.   

Abstract

Extraordinary advances in molecular biology and biotechnology have led to the development of a vast number of therapeutic anti-cancer agents. To reach cancer cells in a tumor, a blood-borne therapeutic molecule, particle, or cell must make its way into the blood vessels of the tumor and across the vessel wall into the interstitium, which it then must migrate through. Unfortunately, tumors often develop in ways that hinder these steps. The goal of research in this area is to analyze each of these steps experimentally and theoretically and integrate the resulting information into a unified theoretical framework. This paradigm of analysis and synthesis has fostered a better understanding of physiological barriers in solid tumors and aided in the development of novel strategies to exploit and/or overcome these barriers for improved cancer detection and treatment.

Entities:  

Mesh:

Year:  1999        PMID: 11701489     DOI: 10.1146/annurev.bioeng.1.1.241

Source DB:  PubMed          Journal:  Annu Rev Biomed Eng        ISSN: 1523-9829            Impact factor:   9.590


  191 in total

1.  A systems approach to drug development and to drug therapy.

Authors:  Walter Wolf
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

2.  Effect of wall compliance and permeability on blood-flow rate in counter-current microvessels formed from anastomosis during tumor-induced angiogenesis.

Authors:  Peng Guo; Bingmei M Fu
Journal:  J Biomech Eng       Date:  2012-04       Impact factor: 2.097

3.  Hand-held spectroscopic device for in vivo and intraoperative tumor detection: contrast enhancement, detection sensitivity, and tissue penetration.

Authors:  Aaron M Mohs; Michael C Mancini; Sunil Singhal; James M Provenzale; Brian Leyland-Jones; May D Wang; Shuming Nie
Journal:  Anal Chem       Date:  2010-10-06       Impact factor: 6.986

4.  In vivo assembly of nanoparticle components to improve targeted cancer imaging.

Authors:  Steven D Perrault; Warren C W Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

5.  Maximizing tumour exposure to anti-neuropilin-1 antibody requires saturation of non-tumour tissue antigenic sinks in mice.

Authors:  Daniela Bumbaca; Hong Xiang; C Andrew Boswell; Ruediger E Port; Shannon L Stainton; Eduardo E Mundo; Sheila Ulufatu; Anil Bagri; Frank-Peter Theil; Paul J Fielder; Leslie A Khawli; Ben-Quan Shen
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  Mechanical control of spheroid growth: distinct morphogenetic regimes.

Authors:  Oswaldo A Lozoya; Sharon R Lubkin
Journal:  J Biomech       Date:  2011-12-06       Impact factor: 2.712

7.  Silver nanosystems for photoacoustic imaging and image-guided therapy.

Authors:  Kimberly Homan; Jignesh Shah; Sobeyda Gomez; Heidi Gensler; Andrei Karpiouk; Lisa Brannon-Peppas; Stanislav Emelianov
Journal:  J Biomed Opt       Date:  2010 Mar-Apr       Impact factor: 3.170

8.  Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging.

Authors:  Ketan B Ghaghada; Cristian T Badea; Lohitash Karumbaiah; Nicole Fettig; Ravi V Bellamkonda; G A Johnson; Ananth Annapragada
Journal:  Acad Radiol       Date:  2011-01       Impact factor: 3.173

9.  Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth.

Authors:  Céline A Blache; Edwin R Manuel; Teodora I Kaltcheva; Andrea N Wong; Joshua D I Ellenhorn; Bruce R Blazar; Don J Diamond
Journal:  Cancer Res       Date:  2012-10-22       Impact factor: 12.701

10.  Pulsed focused ultrasound lowers interstitial fluid pressure and increases nanoparticle delivery and penetration in head and neck squamous cell carcinoma xenograft tumors.

Authors:  Ali Mohammadabadi; Ruby N Huynh; Aniket S Wadajkar; Rena G Lapidus; Anthony J Kim; Christopher B Raub; Victor Frenkel
Journal:  Phys Med Biol       Date:  2020-06-22       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.